These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25346181)

  • 1. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors.
    Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Dominguez C; Llurba E; Gratacós E
    Prenat Diagn; 2015 Feb; 35(2):183-91. PubMed ID: 25346181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
    Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E
    Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
    Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
    BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
    Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 35-37 weeks' gestation.
    Sarno M; Wright A; Vieira N; Sapantzoglou I; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Apr; 57(4):600-606. PubMed ID: 33073902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
    Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
    Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
    Tan MY; Syngelaki A; Poon LC; Rolnik DL; O'Gorman N; Delgado JL; Akolekar R; Konstantinidou L; Tsavdaridou M; Galeva S; Ajdacka U; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Aug; 52(2):186-195. PubMed ID: 29896812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks' gestation.
    Sapantzoglou I; Wright A; Arozena MG; Campos RV; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):75-83. PubMed ID: 33142353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.
    Pihl K; Sørensen S; Stener Jørgensen F
    Fetal Diagn Ther; 2020; 47(4):277-283. PubMed ID: 31622970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for pre-eclampsia at 35-37 weeks' gestation.
    Panaitescu A; Ciobanu A; Syngelaki A; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):501-506. PubMed ID: 29896778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation.
    Wright D; Dragan I; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Feb; 49(2):194-200. PubMed ID: 27671544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35-37 weeks' gestation.
    Döbert M; Wright A; Varouxaki AN; Mu AC; Syngelaki A; Rehal A; Delgado JL; Akolekar R; Muscettola G; Janga D; Singh M; Martin-Alonso R; Dütemeyer V; De Alvarado M; Atanasova V; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):69-75. PubMed ID: 34580947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contingent screening in stratification of pregnancy care based on risk of pre-eclampsia at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Bouariu A; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):553-560. PubMed ID: 34309913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.